2021
DOI: 10.3389/fonc.2020.615400
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Architectures and Cell-of-Origin in Glioblastoma

Abstract: An aggressive primary brain cancer, glioblastoma (GBM) is the most common cancer of the central nervous system in adults. However, an inability to identify its cell-of-origin has been a fundamental issue hindering further understanding of the nature and pathogenesis of GBM, as well as the development of novel therapeutic targets. Researchers have hypothesized that GBM arises from an accumulation of somatic mutations in neural stem cells (NSCs) and glial precursor cells that confer selective growth advantages, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(28 citation statements)
references
References 67 publications
0
28
0
Order By: Relevance
“…Full GBM surgical resection can be made difficult by the infiltrative nature of these tumors and by the need to preserve essential cognitive functions of the patients. From a cellular standpoint, the difficulty in efficiently treating glioblastoma also stems from the high heterogeneity and plasticity of these tumors, beyond the still debated question of the cell of origin of these tumors [ 141 , 142 , 143 , 144 , 145 , 146 ].…”
Section: Brain Tumorsmentioning
confidence: 99%
“…Full GBM surgical resection can be made difficult by the infiltrative nature of these tumors and by the need to preserve essential cognitive functions of the patients. From a cellular standpoint, the difficulty in efficiently treating glioblastoma also stems from the high heterogeneity and plasticity of these tumors, beyond the still debated question of the cell of origin of these tumors [ 141 , 142 , 143 , 144 , 145 , 146 ].…”
Section: Brain Tumorsmentioning
confidence: 99%
“…The existence of these cells is a subject of controversy, due to lack of specific markers or standard identification strategies. However, the presence of CSCs has been consistently demonstrated in several cancers, such as leukemia, glioblastoma, breast, ovarian, colorectal, prostate, lung, liver, and kidney cancers [28][29][30][31][32][33], and it appears that CSCs are also present in OS. Specifically, OS CSCs share similarities with mesenchymal stem cells (MSCs), which points to a probable bone-marrow MSC and/or mesenchymal progenitor cell origin for OS CSCs [10,11,[34][35][36][37].…”
Section: Osteosarcoma Overviewmentioning
confidence: 99%
“…Several studies have shown that metabolic and genetic disorders there are in patients with diabetes and cancer [14][15][16]. In addition, circRNAs can exert modulatory effects on cancer-related processes, such as tumorigenesis, tumor progression, and apoptosis [17,18].…”
Section: Introductionmentioning
confidence: 99%